These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20820656)

  • 1. pH-Sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriers.
    Luong A; Issarapanichkit T; Kong SD; Fong R; Yang J
    Org Biomol Chem; 2010 Nov; 8(22):5105-9. PubMed ID: 20820656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic hydrolysis of N-Ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery.
    Kong SD; Luong A; Manorek G; Howell SB; Yang J
    Bioconjug Chem; 2007; 18(2):293-6. PubMed ID: 17261055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Förster resonance energy transfer.
    Chen KJ; Chiu YL; Chen YM; Ho YC; Sung HW
    Biomaterials; 2011 Apr; 32(10):2586-92. PubMed ID: 21251711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a folate receptor (FR)-targeted indenoisoquinoline using a pH-sensitive N-ethoxybenzylimidazole (NEBI) bifunctional cross-linker.
    Cao Y; Yang J
    Bioconjug Chem; 2014 May; 25(5):873-8. PubMed ID: 24758386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.
    Kufleitner J; Worek F; Kreuter J
    J Microencapsul; 2010; 27(7):594-601. PubMed ID: 20923399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells.
    Yan Y; Johnston AP; Dodds SJ; Kamphuis MM; Ferguson C; Parton RG; Nice EC; Heath JK; Caruso F
    ACS Nano; 2010 May; 4(5):2928-36. PubMed ID: 20420377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Responsive copolymer assemblies for controlled release of doxorubicin.
    Gillies ER; Fréchet JM
    Bioconjug Chem; 2005; 16(2):361-8. PubMed ID: 15769090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge-conversional poly(amino acid)s derivatives as a drug delivery carrier in response to the tumor environment.
    Yoon SR; Yang HM; Park CW; Lim S; Chung BH; Kim JD
    J Biomed Mater Res A; 2012 Aug; 100(8):2027-33. PubMed ID: 22581644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetals as pH-sensitive linkages for drug delivery.
    Gillies ER; Goodwin AP; Fréchet JM
    Bioconjug Chem; 2004; 15(6):1254-63. PubMed ID: 15546191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
    Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
    Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
    Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes.
    Zhang X; Meng L; Lu Q; Fei Z; Dyson PJ
    Biomaterials; 2009 Oct; 30(30):6041-7. PubMed ID: 19643474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
    Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
    Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin.
    Yang SR; Lee HJ; Kim JD
    J Control Release; 2006 Aug; 114(1):60-8. PubMed ID: 16828916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy.
    Lai PS; Lou PJ; Peng CL; Pai CL; Yen WN; Huang MY; Young TH; Shieh MJ
    J Control Release; 2007 Sep; 122(1):39-46. PubMed ID: 17628166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.